ENDONOVO THERAPEUTICS, INC. Notes Payable
ENDONOVO THERAPEUTICS, INC. (ENDV) had Notes Payable of $7.09 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:NotesPayable · last filed 2023-12-29
- 2023-09-30: Notes Payable $7.09M.
- 2023-06-30: Notes Payable $7.05M.
- 2023-03-31: Notes Payable $6.91M.
- 2022-12-31: Notes Payable $7.16M.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2023-09-30 | $7.09M 10-Q · filed 2023-12-29 | |
| 2023-06-30 | $7.05M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $6.91M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $7.16M 10-Q · filed 2023-12-29 | |
| 2022-09-30 | $7.27M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $7.41M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $7.35M 10-Q · filed 2022-05-19 | |
| 2021-12-31 | $7.26M 10-Q · filed 2023-12-29 | |
| 2021-09-30 | $6.82M 10-Q · filed 2021-11-19 | |
| 2021-06-30 | $6.73M 10-Q · filed 2021-08-23 | |
| 2020-12-31 | $6.84M 10-K · filed 2023-04-17 | |
| 2019-12-31 | $6.87M 10-K · filed 2022-04-14 | |
| 2016-12-31 | $70.00K 10-K · filed 2017-04-17 | |
| 2016-03-31 | $2.39M 10-Q · filed 2016-05-27 | |
| 2015-12-31 | $1.38M 10-Q · filed 2016-05-27 | $1.93M 10-K · filed 2016-04-05 |
| 2015-09-30 | $1.74M 10-Q · filed 2015-11-23 | |
| 2015-03-31 | $1.29M 10-Q · filed 2015-06-15 | |
| 2014-12-31 | $1.38M 10-K · filed 2016-05-17 | $1.15M 10-K · filed 2015-06-15 |
| 2014-03-31 | $1.38M 10-Q · filed 2015-06-15 | |
| 2013-12-31 | $710.07K 10-K · filed 2016-05-17 | $1.15M 10-K · filed 2015-06-15 |
| 2012-12-31 | $287.66K 10-K/A · filed 2013-05-03 | |
| 2012-11-30 | $64.46K 10-K · filed 2015-06-15 |